Vorapaxar Meets End Point But Ups Bleeding Vorapaxar Meets End Point But Ups Bleeding
In its second phase 3 trial, Merck's novel antiplatelet agent reduced ischemic events but increased bleeding, including ICH. Results looked more promising in patients without a history of stroke. Heartwire (Source: Medscape Today Headlines)
Physical Punishment Harms Children’s Long-Term DevelopmentPhysical Punishment Harms Children’s Long-Term Development
Physical punishment, including spanking and slapping, can damage a child's long-term development and increase the risk of aggression, antisocial behavior, and mental illness, a new analysis shows. Medscape Medical News (Source: Medscape Today Headlines)